According to FutureWise analysis the market for Agoraphobia is expected to reach US$ 1.71 billion by 2031 at a CAGR of 7.12%.
Agoraphobia is an anxiety disorder that causes overwhelming fear of being trapped, helpless, or unable to find a way to escape or seek assistance. Because of fear and anxiety, an individual with agoraphobia usually avoids new places and unfamiliar situations. When confronted with a stressful situation, individuals with agoraphobia commonly exhibit panic attack symptoms, including a rapid heartbeat and feelings of nausea. They may also experience these symptoms before entering the situation they fear. In some cases, the condition can be so intense that individual avoid daily activities and stay home most of the day. For instance, according to the NIMH, approximately 0.8 percent of American adults suffer from agoraphobia, and roughly 40 percent of cases are classified as severe. When the disorder is more advanced, agoraphobia can be very disabling. Individuals with agoraphobia often realize their fear is irrational, but they cannot do anything about it.
Patients with mild or moderate panic agoraphobia can choose between psychotherapy and pharmacotherapy for adequate symptom management. Studies have generally concluded that cognitive-behavioral therapy (CBT) effectively manages and alleviates target symptoms, reduces other anxiety symptoms, and improves the patient's quality of life. For patients with more severe forms of agoraphobia or those individuals who prefer pharmacotherapy over psychotherapy, there are several effective options for medication management. Selective serotonin receptor inhibitors (SSRIs) are considered first-line therapy, with therapeutic doses being the same as depression. Serotonin-norepinephrine reuptake inhibitors (SNRIs), benzodiazepines, and TCAs (tricyclic antidepressants) have also been effective alternatives to SSRIs in treating panic disorder and agoraphobia. SSRIs are generally preferable to these other medications because of the side effect profile, affordability, availability, decreased potential for abuse, and better tolerability.
FutureWise Market Research has published a report that provides an insightful agoraphobia market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.
According to the analysis conducted by FutureWise research analysts, agoraphobia market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.